全球生物製药物流市场规模、份额、趋势和成长分析报告（2026-2034）

预计生物製药物流市场将从 2025 年的 1,665.9 亿美元成长到 2034 年的 3,275.1 亿美元，2026 年至 2034 年的复合年增长率为 7.8%。

随着製药和生物技术产业的持续成长，全球生物製药物流市场也不断扩张。生物製药物流涵盖对温度敏感的药品、疫苗和生物製药的储存、处理和运输。严格的温度控制和合规性对于确保这些敏感医疗产品的安全性和有效性至关重要。

市场成长主要受全球对生物製药、疫苗和先进治疗方法的需求不断增长所驱动。製药生产的扩张和医疗供应链的全球化，使得对专业物流解决方案的需求日益增加。此外，低温运输技术和监控系统的进步，也提高了生物製药运输的可靠性和效率。

随着对生物製药和个人化药物的需求不断增长，生物製药物流市场预计将迎来显着成长。物流供应商正投资于先进的低温运输基础设施和数位化监控技术，以确保产品完整性。随着全球医疗保健体系的扩展和药物创新技术的进步，该市场有望实现强劲成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球生物製药物流市场：依产品类型划分

• 市场分析、洞察与预测
• 低温运输物流
• 非低温运输物流

第五章 全球生物製药物流市场：依运输服务类型划分

• 市场分析、洞察与预测
• 运输方式（空运、海运、陆运）
• 仓库和存储

第六章 全球生物製药物流市场：依最终用户划分

• 市场分析、洞察与预测
• 製药
• 生物製药
• 药局
• 医院
• 诊所
• 超级市场
• 其他的

第七章 全球生物製药物流市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Panalpina World Transport Ltd
  • United Parcel Service Inc
  • XPO Logistics Inc
  • Kuehne+Nagel International AG
  • Fedex Corporation
  • CH Robinson Worldwide Inc
  • Panalpina Group
  • Deutsche Post DHL Group
  • Amerisource Bergen Corporation
  • Ceva Logistics LLC,

The Biopharmaceutical Logistic Market size is expected to reach USD 327.51 Billion in 2034 from USD 166.59 Billion (2025) growing at a CAGR of 7.8% during 2026-2034.

The Global Biopharmaceutical Logistic Market is expanding as the pharmaceutical and biotechnology industries continue to grow. Biopharmaceutical logistics involves the storage, handling, and transportation of temperature-sensitive drugs, vaccines, and biological products. Maintaining strict temperature control and regulatory compliance is essential to ensure the safety and effectiveness of these sensitive healthcare products.

Market growth is driven by increasing global demand for biologic drugs, vaccines, and advanced therapies. The expansion of pharmaceutical manufacturing and the globalization of healthcare supply chains are increasing the need for specialized logistics solutions. In addition, advancements in cold chain technologies and monitoring systems are improving the reliability and efficiency of biopharmaceutical transportation.

In the future, the biopharmaceutical logistics market is expected to grow significantly as the demand for biologic medicines and personalized therapies increases. Logistics providers are investing in advanced cold chain infrastructure and digital monitoring technologies to ensure product integrity. With the expansion of global healthcare systems and pharmaceutical innovation, the market is likely to experience strong growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Products Type

• Cold Chain Logistics
• Non-Cold Chain Logistics

By Transport Service Type

• Transportation (Air Freight, Sea Freight, Overland Transportation)
• Warehouse And Storage

By End Users

• Pharmaceuticals
• Biopharmaceuticals
• Pharmacies
• Hospitals
• Clinics
• Supermarkets
• Others

COMPANIES PROFILED

• Panalpina World Transport Ltd, United Parcel Service Inc, XPO Logistics Inc, Kuehne Nagel International AG, Fedex Corporation, CH Robinson Worldwide Inc, Panalpina Group, Deutsche Post DHL Group, Amerisource Bergen Corporation, Ceva Logistics LLC,
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOPHARMACEUTICAL LOGISTIC MARKET: BY PRODUCTS TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Products Type
• 4.2. Cold Chain Logistics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Non-Cold Chain Logistics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOPHARMACEUTICAL LOGISTIC MARKET: BY TRANSPORT SERVICE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Transport Service Type
• 5.2. Transportation (Air Freight, Sea Freight, Overland Transportation) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Warehouse And Storage Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOPHARMACEUTICAL LOGISTIC MARKET: BY END USERS 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Users
• 6.2. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Biopharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Supermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOPHARMACEUTICAL LOGISTIC MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Products Type
  • 7.2.2 By Transport Service Type
  • 7.2.3 By End Users
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Products Type
  • 7.3.2 By Transport Service Type
  • 7.3.3 By End Users
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Products Type
  • 7.4.2 By Transport Service Type
  • 7.4.3 By End Users
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Products Type
  • 7.5.2 By Transport Service Type
  • 7.5.3 By End Users
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Products Type
  • 7.6.2 By Transport Service Type
  • 7.6.3 By End Users
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOPHARMACEUTICAL LOGISTIC INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Panalpina World Transport Ltd
  • 9.2.2 United Parcel Service Inc
  • 9.2.3 XPO Logistics Inc
  • 9.2.4 Kuehne + Nagel International AG
  • 9.2.5 Fedex Corporation
  • 9.2.6 C.H. Robinson Worldwide Inc
  • 9.2.7 Panalpina Group
  • 9.2.8 Deutsche Post DHL Group
  • 9.2.9 Amerisource Bergen Corporation
  • 9.2.10 Ceva Logistics LLC,